Lgr5+ cells are not present in normal liver tissue; therefore, the removal of β-catenin in pro-tumorigenic liver tissue such as I-HCA may lead to abnormal immune responses in HCC progression with the suppression of Lgr5 and PLA2G2A. The gene discussed is LGR5; the disease is hepatocellular carcinoma.